3221 - 3230 of 7939 Results
Title
Year
- CD4 T cells mediate brain inflammation and neurodegeneration in a mouse model of Parkinson's disease2021OPENTitle: CD4 T cells mediate brain inflammation and neurodegeneration in a mouse model of Parkinson's diseaseJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 144Issue #: 7Start Page: 2047End Page: 2059Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/brain/awab103Best OA location URL: https://academic.oup.com/brain/article-pdf/144/7/2047/39769283/awab103.pdfCitation Count: 184
- How COVID-19 will boost remote exercise-based treatment in Parkinson’s disease: a narrative review2021RESTRICTEDTitle: How COVID-19 will boost remote exercise-based treatment in Parkinson’s disease: a narrative reviewJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 7Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-021-00160-3Best OA location URL: https://www.nature.com/articles/s41531-021-00160-3.pdfCitation Count: 59
- Neurological outcome and quality of life 3 months after COVID‐19: A prospective observational cohort study2021OPENTitle: Neurological outcome and quality of life 3 months after COVID‐19: A prospective observational cohort studyJournal Name: European Journal of NeurologyPublisher: WileyVol: 28Issue #: 10Start Page: 3348End Page: 3359Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1111/ene.14803Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/ene.14803Citation Count: 156
- Screen Fast, Screen Faster: A Pilot Study to Screen for Depressive Symptoms Using the Beck Depression Inventory Fast Screen in Parkinson's Disease With Mild Cognitive Impairment2021OPENTitle: Screen Fast, Screen Faster: A Pilot Study to Screen for Depressive Symptoms Using the Beck Depression Inventory Fast Screen in Parkinson's Disease With Mild Cognitive ImpairmentJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 12Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2021.640137Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2021.640137/pdfCitation Count: 9
-
RESTRICTEDTitle: The Role of Genetic Testing for Parkinson’s DiseaseJournal Name: Current Neurology and Neuroscience ReportsPublisher: Springer Science and Business Media LLCVol: 21Issue #: 4Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s11910-021-01100-7Citation Count: 14
-
RESTRICTEDTitle: Type 2 Diabetes as a Determinant of Parkinson's Disease Risk and ProgressionJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 6Start Page: 1420End Page: 1429Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1002/mds.28551Best OA location URL: https://discovery.ucl.ac.uk/10120800/1/Noyce_mds.28551.pdfCitation Count: 108
- ATP13A2 Regulates Cellular α-Synuclein Multimerization, Membrane Association, and Externalization2021OPENTitle: ATP13A2 Regulates Cellular α-Synuclein Multimerization, Membrane Association, and ExternalizationJournal Name: International Journal of Molecular SciencesPublisher: MDPI AGVol: 22Issue #: 5Start Page: 2689End Page: 2689Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.3390/ijms22052689Best OA location URL: https://www.mdpi.com/1422-0067/22/5/2689/pdf?version=1615453355Citation Count: 18
-
OPENTitle: Data imputation and compression for Parkinson's disease clinical questionnairesJournal Name: Artificial Intelligence in MedicinePublisher: Elsevier BVVol: 114Issue #:Start Page: 102051End Page: 102051Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.artmed.2021.102051Best OA location URL: https://hal.archives-ouvertes.fr/hal-02570967v3/file/PatiNAE_hal.pdfCitation Count: 21
-
OPENTitle: GDNF signaling in subjects with minimal motor deficits and Parkinson's diseaseJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 153Issue #:Start Page: 105298End Page: 105298Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.nbd.2021.105298Best OA location URL: https://doi.org/10.1016/j.nbd.2021.105298Citation Count: 21
-
OPENTitle: Predicting Parkinson's disease trajectory using clinical and neuroimaging baseline measuresJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 85Issue #:Start Page: 44End Page: 51Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.02.026Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8127393Citation Count: 16